Clinical Trial Update: A Study of Nilotinib in Growing Vestibular Schwannomas [Phase 2]

View source ↗

Summary

The Phase 2 study of nilotinib in growing vestibular schwannomas has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vestibular Schwannoma

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Growing Vestibular Schwannomas | Phase 2 | Status: TERMINATED